Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steinert Disease”

220 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 220 results

Not applicableUnknownNCT02269865
What this trial is testing

Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1
Stanford University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05673928
What this trial is testing

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

Who this might be right for
Metastatic Solid TumorBrain Metastases
M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT00928330
What this trial is testing

Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based Therapy

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 57
Not applicableLooking for participantsNCT05989620
What this trial is testing

Long-Term Development of Muscular Dystrophy Outcome Assessments

Who this might be right for
LGMD1BLGMD1CLGMD1D+26 more
Virginia Commonwealth University 1,000
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Not applicableActive Not RecruitingNCT05889988
What this trial is testing

Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

Who this might be right for
Breast Neoplasm
Mayo Clinic 36
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableLooking for participantsNCT06147414
What this trial is testing

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Who this might be right for
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, IncludingSickle Cell DiseaseCystic Fibrosis+12 more
Assistance Publique - Hôpitaux de Paris 550
Large-scale testing (Phase 3)Looking for participantsNCT07486934
What this trial is testing

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)DM1Myotonic Dystrophy+2 more
Dyne Therapeutics 150
Not applicableStudy completedNCT04001920
What this trial is testing

Effects of a Multiple Component Training Program on Muscles in Adults With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Cynthia Gagnon 11
Not applicableEnrolling By InvitationNCT06979024
What this trial is testing

A Registered Observational Cohort Study of Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
First Affiliated Hospital of Fujian Medical University 300
Large-scale testing (Phase 3)Active Not RecruitingNCT03975647
What this trial is testing

Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Seagen, a wholly owned subsidiary of Pfizer 466
Testing effectiveness (Phase 2)Study completedNCT02858908
What this trial is testing

Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy 1
AMO Pharma Limited 16
Not applicableStudy completedNCT05662150
What this trial is testing

Low-frequency Repetitive Nerve Stimulation in Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Vrije Universiteit Brussel 9
Not applicableLooking for participantsNCT07415837
What this trial is testing

Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies

Who this might be right for
Duchenne / Becker Muscular DystrophyDystrophia Myotonica 1Congenital Myopathies+1 more
University Hospital, Clermont-Ferrand 104
Large-scale testing (Phase 3)Enrolling By InvitationNCT06549400
What this trial is testing

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.

Who this might be right for
Myotonic Dystrophy
Lupin Ltd. 176
Large-scale testing (Phase 3)Enrolling By InvitationNCT07008469
What this trial is testing

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

Who this might be right for
Myotonic Dystrophy Type 1DM1Myotonic Dystrophy+5 more
Avidity Biosciences, Inc. 199
Not applicableNot Yet RecruitingNCT07732439
What this trial is testing

An Ambispective Natural History Study in Myotonic Dystrophy Patients Linking Retrospective Data Captured From the DM-Scope Registry With a Prospective 24-month Follow-up Period

Who this might be right for
Myotonic Dystrophy 1Myotonic Dystrophy 2
Lupin Ltd. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03587740
What this trial is testing

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 111
Early research (Phase 1)Study completedNCT04509596
What this trial is testing

DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Dizal Pharmaceuticals 23
Next Page